Key points are not available for this paper at this time.
inactivating the CCR2-STAT1/NFκB/ERK signaling pathways.
Guo et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: